The recent pressure on Seagen Inc.’s (NASDAQ: SGEN) stock may offer a nearer-term opportunity, but the biotech's position as an attractive strategic target is “too intriguing to ignore.”
Remitly and Rewire share a commitment to transform the lives of millions of immigrants and their families with the most trusted and innovative financial services products.
Remitly Global, Inc., (NASDAQ:RELY)
Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with Everest Medicines to transfer all development and commercialization rights to Gilead for Trodelvy® (sacituzumab govitecan) in Greater China, South Korea, Singapore, Indonesia, Philippines, Vietnam, Thailand, Malaysia and Mongolia.
Positions Navitas as the only pure-play, next-generation power semiconductor company
EL SEGUNDO, Calif., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Navitas Semiconductor (NASDAQ:NVTS), the industry leader in gallium nitride
Unity Software Inc (NYSE:U) unanimously rejected the unsolicited proposal from Applovin Corp (NASDAQ:APP) without expecting any superior proposal. Unity reaffirmed its allegiance to ironSource…
Boston Scientific Corporation (NYSE:BSX) has acquired privately-held Obsidio Inc that developed the Gel Embolic Material (GEM) technology to embolize blood vessels in the…